Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for P3 Health Partners (PIII) over the last 4 years, with FY2024 value amounting to $496.4 million.

  • P3 Health Partners' Total Current Liabilities rose 459.79% to $424.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $424.0 million, marking a year-over-year increase of 459.79%. This contributed to the annual value of $496.4 million for FY2024, which is 6581.88% up from last year.
  • P3 Health Partners' Total Current Liabilities amounted to $496.4 million in FY2024, which was up 6581.88% from $299.4 million recorded in FY2023.
  • Over the past 5 years, P3 Health Partners' Total Current Liabilities peaked at $496.4 million during FY2024, and registered a low of $90.6 million during FY2020.
  • Moreover, its 4-year median value for Total Current Liabilities was $270.5 million (2022), whereas its average is $282.0 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 2387.94% in 2023, then skyrocketed by 6581.88% in 2024.
  • Over the past 4 years, P3 Health Partners' Total Current Liabilities (Annual) stood at $90.6 million in 2020, then soared by 166.69% to $241.7 million in 2022, then increased by 23.88% to $299.4 million in 2023, then surged by 65.82% to $496.4 million in 2024.
  • Its last three reported values are $496.4 million in FY2024, $299.4 million for FY2023, and $241.7 million during FY2022.